Pronota (BEL)

Pronota is using its unique protein biomarker discovery and validation technologies to develop a rich pipeline of high value diagnostic tests. Because we start with no a priori assumptions about the identity of candidate markers, and because our technology allows us to search for proteins present in very low amounts in blood, we are generating novel, highly patentable, candidates with strong diagnostic utility. Our lead program is in the pre-eclampsia area where our test can stratify patients at early time points during the pregnancy.